Hemorrhagic Fever - 27 Studies Found
Enrolling by invitation |
: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever : Viral Hemorrhagic Fever : 2015-06-24 : Drug: Ribavirin |
Active, not recruiting |
: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans : Crimean-Congo Hemorrhagic Fever : 2017-01-11 :
|
Enrolling by invitation |
: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities :
: 2009-10-08 : Drug: Ribavirin (Virazole) Injection The drug is to be adm |
Active, not recruiting |
: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda : Hemorrhagic Fever, Ebola : 2015-01-29 :
|
Recruiting |
: Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi : Ebola Hemorrhagic Fever : 2016-09-14 : Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |
Recruiting |
: Open Study of the Duration of Immunity After Vaccination With GamEvac : Hemorrhagic Fever, Ebola : 2016-09-14 : Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |
Recruiting |
: Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo : Hemorrhagic Fever, Ebola : 2015-11-04 :
|
Recruiting |
: Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo : Hemorrhagic Fever, Ebola : 2016-01-08 :
|
Withdrawn |
: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers : Ebola Hemorrhagic Fever : 2012-05-03 :
|
Completed |
: Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus : Ebola Hemorrhagic Fever : 2011-05-10 :
|